ストックスクリーナーアプリを入手
28.46
1.86%
0.52
アフターアワーズ：
28.46
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Harmony Biosciences Presents Positive Data on ZYN002 for Fragile X Syndrome - MSN
Geode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) Technical Data - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by JPMorgan Chase & Co. - Defense World
Franklin Resources Inc. Has $1.10 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Appoints Ron Philip to Board of Directors - MSN
Harmony Biosciences (NASDAQ:HRMY) Earns “Buy” Rating from HC Wainwright - Defense World
Breaking Down Harmony Biosciences Hldgs: 13 Analysts Share Their Views - Benzinga
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome - BioSpace
Oppenheimer maintains Harmony Biosciences Outperform rating By Investing.com - Investing.com South Africa
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Oppenheimer on Harmony Biosciences (HRMY): 'we remain pleased with WAKIX's 4Q24 performance' - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Connect - markets.businessinsider.com
Harmony Biosciences reports progress in Fragile X syndrome gel treatment - Investing.com
Breakthrough: New Fragile X Treatment Achieves 73% Success Rate in Long-term Study - Stock Titan
HRMY stock touches 52-week low at $27.87 amid market shifts By Investing.com - Investing.com South Africa
HRMY stock touches 52-week low at $27.87 amid market shifts - Investing.com India
Corebridge Financial Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Vanguard Group Inc. Has $162.88 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Increased by Vanguard Group Inc. - Defense World
Arrowstreet Capital Limited Partnership Has $10.21 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - Insider Monkey
Harmony Biosciences Appoints Ron Philip to Board - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Investors to Learn More About the Investigation - markets.businessinsider.com
Harmony Biosciences Appoints Ron Philip To Board - citybiz
Harmony Biosciences expands board with new director - Investing.com India
Harmony Biosciences Appoints Biotech Leader Ron Philip To Its Board Of Directors - MarketScreener
Harmony Biosciences expands board with new director By Investing.com - Investing.com UK
Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors - Business Wire
Strategic Win: Harmony Biosciences Taps Gene Therapy Pioneer Ron Philip for Board Role - Stock Titan
Raymond James Financial Inc. Invests $1.30 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Thrivent Financial for Lutherans Acquires 5,880 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect - markets.businessinsider.com
Teacher Retirement System of Texas Purchases 3,964 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
HighTower Advisors LLC Has $392,000 Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Harmony Biosciences to Present at 24th Annual Needham Virtual Healthcare Conference - MyChesCo
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer - MyChesCo
Quantbot Technologies LP Grows Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to Connect - Markets Insider
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Swiss National Bank - Defense World
Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 3.2%What's Next? - MarketBeat
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Harmony Biosciences appoints Adam Zaeske as Chief Commercial Officer - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
2.51%
大文字化:
|
ボリューム (24 時間):